INTRODUCTION
============

*Acinetobacter baumannii* (*A. baumannii*) has emerged worldwide as an important opportunistic nosocomial pathogen, especially in intensive care unit (ICU) patients.[@B1] Carbapenems have been widely used to treat serious infections associated with multidrug-resistant (MDR) *A. baumannii*, but carbapenem resistance has been increasingly reported worldwide.[@B2],[@B3] Moreover, most carbapenem-resistant *A. baumannii* strains are multidrug or even pandrug resistant.[@B4] In Korea, imipenem-resistant *A. baumannii* isolates from a university hospital reached 32.5%.[@B5] Among the various mechanisms of carbapenem resistance in *A. baumannii*, carbapenemase of the molecular class D OXA enzymes has emerged as the main source of carbapenem resistance.[@B6] A previous study reported that among ten university hospitals in Korea, 78.3% of carbapenem-resistant *A. baumannii* isolates were caused by OXA-23-like enzymes, among which ST22 was the most prevalent type.[@B7] Park, et al.[@B8] reported that two major clones of carbapenem-resistant *A. baumannii*, ST22 and ST28, were found in five tertiary care hospitals.[@B8] However, these two clones have so far been studied only in tertiary hospital isolates. This study was performed to analyze the genetic diversity and clonal distribution of carbapenem-resistant *A. baumannii* isolates among non-tertiary hospitals in Korea.

MATERIALS AND METHODS
=====================

Bacterial isolates and reference strains
----------------------------------------

A total of 315 consecutive *A. baumannii* clinical isolates were collected from 24 non-tertiary South Korea hospitals between 2004 and 2006. Among these isolates, 50 were carbapenem-resistant, of which 36 nonrepetitive isolates from 17 hospitals in 8 provinces were selected for this study. The strains were propagated at 37℃ in Luria-Bertani broth or agar. The clinical isolates were identified by using the Vitek II system (bioMerieux, Marcy-I\'Etoile, France). Species identification was performed by partial *rpoB* gene sequencing.[@B9]

Antimicrobial susceptibility test
---------------------------------

Antimicrobial susceptibility tests were performed using the minimal inhibitory concentrations of Etest (AB BIODISK, Piscataway, NJ, USA), based on the results reported by the Clinical and Laboratory Standards Institute.[@B10] Eleven antimicrobial agents were tested: amikacin, gentamicin, ticarcillin-clavulanic acid, piperacillin, imipenem, meropenem, ciprofloxacin, ceftazidime, cefepime and polymyxin B, according to the manufacturer\'s instructions. *Escherichia coli* ATCC 25922 was used for quality control in antimicrobial susceptibility testing.

Multilocus sequencing typing (MLST)
-----------------------------------

MLST was performed for all isolates according to the method described previously.[@B11] Fragments of seven housekeeping genes (*gltA*, *gyrB*, *gdhB*, *recA*, *cpn60*, *gpi*, *rpoD*) were amplified by PCR and sequenced. Allele numbers were assigned as sequence types (STs) after distinct allele sequences were submitted to a dedicated data base (<http://pubmlst.org>). A clonal complex was used to assess the genetic relatedness of the STs; the most stringent definition-sharing alleles at 6 of 7 loci-was used.[@B12]

Repetitive-sequence-based PCR (Rep-PCR)
---------------------------------------

Rep-PCR was performed by using the DiversiLab system (bioMerieux SA, Grenoble, France) to investigate the clonal relatedness of *A. baumannii* isolates. Results were analyzed with DiversiLab software using the Kullback-Leibler method to determine distance matrices, and the unweighted pair group method with arithmetic averages to create a dendrogram. Sample relationships were designated as follows: pattern, no band differences (indistinguishable); group, 1 to 2 band differences (similar); and different group, 3 or more band differences. Each group corresponded to an outbreak.

Identification of carbapenemase genes
-------------------------------------

PCR was performed to detect the genes encoding MBLs (IMP-1 variants and VIM-2 variants) and OXA carbapenemase (OXA-23-like, OXA-24-like, OXA-51-like and OXA-58-like) according to the method described previously.[@B13] The sequence analysis of PCR products was carried out by request at Macrogen (<http://macrogen.co.kr>).

RESULTS
=======

Antimicrobial susceptibilities
------------------------------

The isolated carbapenem-resistant *A. baumannii* isolates showed 100% resistance to gentamicin, piperacillin, ciprofloxacin, ceftazidime and cefepime. In addition, they showed a high resistance against amikacin (34/36, 94.4%), but a complete susceptibility to polymyxin B ([Table 1](#T1){ref-type="table"}).

Distribution and molecular epidemiology of β-lactamase genes
------------------------------------------------------------

Two unique STs among the 36 carbapenem-resistant *A. baumannii* isolates were revealed by MLST analysis ([Table 2](#T2){ref-type="table"}). Two clones were prevalent among 36 isolates: ST69 (17 isolates, 47.2%) and ST92 (19 isolates, 52.8%). All 36 *A. baumannii* isolates carried the *bla*OXA-51-like gene. Fourteen isolates (38.9%) had the ISA*ba1*-activated *bla*OXA-23-like gene, and 25 isolates (69.4%) had the ISA*ba1*-activated *bla*OXA-51-like gene. Coexistence of *bla*OXA-23 and ISA*ba1*-activated *bla*OXA-51-like genes was detected in three isolates (8.3%). No *bla*OXA-24-like, *bla*OXA-58 like, IMP-1 or VIM-2 genes were found.

Clonal relationship
-------------------

The results of rep-PCR showed that carbapenem-resistant *A. baumannii* isolates were clustered into eight distinctive band patterns, including five clonally related groups. A 96.5% similarity line was obtained by DiversiLab software to represent the best match between pattern assignments and the dendrogram ([Fig. 1](#F1){ref-type="fig"}). The following differences in rep-PCR patterns were observed between ST69 and ST92: band pattern 1 \[2 isolates (ST69)\], band pattern 2 \[2 isolates (ST69)\], band pattern 3 \[5 isolates (ST69), 1 isolate (ST92)\], band pattern 4 \[3 isolates (ST69), 1 isolate (ST92)\], band pattern 5 \[1 isolate (ST69), 13 isolates (ST92)\], band pattern 6 \[4 isolates (ST92)\], band pattern 7 \[3 isolates (ST69)\], and band pattern 8 \[1 isolate (ST69)\] ([Table 2](#T2){ref-type="table"}).

DISCUSSION
==========

*A. baumannii* is a rapidly emerging pathogen in hospitals, frequently causing nosocomial outbreaks in ICUs. Several hospital outbreaks caused by MDR *A. baumannii* clones have been described in Europe and worldwide. The incidence of carbapenem-resistant *A. baumannii* has increased worldwide since its first emergence in New York in 1991.[@B14] Despite the high ratio of carbapenem-resistant *A. baumannii* isolates in Korean tertiary hospitals,[@B15] there have been no reports about the antimicrobial susceptibility, resistance mechanisms or molecular epidemiology of carbapenem-resistant *A. baumannii* in Korean non-tertiary hospitals. In this study, we used MLST and rep-PCR to investigate the clonality of carbapenem-resistant *A. baumannii* isolates in non-tertiary hospitals throughout various regions of Korea. In MLST, two distinctive clones, ST92 and its double-locus variant ST69, were identified among 36 carbapenem-resistant *A. baumannii* isolates. Our results corresponded well with those of an earlier study which reported that ST92 (ST22 was redesignated ST92 after an update of allelic profiles at the database website <http://pubmist.org>) may contribute to the high carbapenem resistance rates of *Acinetobacter* isolates in Korean university hospitals.[@B7] Wide dissemination of non-carbapenem-susceptible ST92 isolates has also been described in China and Korea.[@B16] In addition, Park, et al.[@B8] demonstrated that ST69 was another major carbapenem-resistant clone found in tertiary care hospitals in Korea. ST28, however, was not identified in this study, which was previously indicated as a major carbapenem-resistant clone found in Korea.[@B8] There were no distinctive characteristics in regards to *bla*OXA type in the two major clones, ST92 and ST69, as shown in [Table 2](#T2){ref-type="table"}. Because both clones were found in most regions, they may be distributed ubiquitously throughout Korea. Most of the isolates of the ST92 clone (17/19, 89.5%) were clustered into three rep-PCR band groups. The ISA*ba1*-activated OXA-23-like β-lactamase gene was found in the isolates of ST69 (9 isolates) and ST92 (5 isolates).

In summary, we investigated the antimicrobial resistance and clonality of carbapenem-resistant *A. baumannii* isolates in non-tertiary hospitals throughout Korea. Carbapenem-resistant *A. baumannii* isolates in Korea may be due to two major clones, ST69 and ST92, which have disseminated nationwide in not only tertiary hospitals but also in non-tertiary hospitals throughout Korea.
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The Results of Antimicrobial Susceptibility in 36 Carbapenem-Resistant *A. baumannii* Isolates
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AMK, amikacin; GEN, gentamicin; TIM, ticarcillin-clavulanic acid; PIP, piperacillin; IMP, imipenem; MEM, meropenem; CIP, ciprofloxacin; CAZ, ceftazidime; CPM, cefepime; PMB, polymyxin B; *A. baumannii*, *Acinetobacter baumannii*.
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STs, sequence types; *A. baumannii*, *Acinetobacter baumannii*; CSF, cerebral spinal fluid.
